NW
CRL icon

NewEdge Wealth’s Charles River Laboratories CRL Stock Holding History

NewEdge Wealth’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
+1,091
New +$194K ﹤0.01% 1106
2026
Q1 		– Sell
-2,580
Closed -$515K – 1156
2025
Q4 		$515K Buy
+2,580
New +$468K 0.01% 829
2025
Q2 		– Sell
-21,364
Closed -$3.22M – 975
2025
Q1 		$3.22M Buy
21,364
+4,403
+26% +$738K 0.06% 253
2024
Q4 		$3.13M Sell
16,961
-4,531
-21% -$873K 0.05% 264
2024
Q3 		$4.23M Buy
21,492
+1,135
+6% +$236K 0.08% 221
2024
Q2 		$4.21M Buy
20,357
+234
+1% +$53K 0.09% 190
2024
Q1 		$4.63M Buy
20,123
+1,927
+11% +$460K 0.1% 176
2023
Q4 		$4.3M Buy
18,196
+1,301
+8% +$256K 0.11% 159
2023
Q3 		$3.31M Buy
16,895
+1,524
+10% +$313K 0.1% 174
2023
Q2 		$3.23M Buy
15,371
+615
+4% +$122K 0.11% 180
2023
Q1 		$2.98M Buy
14,756
+584
+4% +$132K 0.11% 170
2022
Q4 		$3.09M Buy
14,172
+50
+0.4% +$10.9K 0.13% 146
2022
Q3 		$2.78M Buy
14,122
+921
+7% +$199K 0.13% 150
2022
Q2 		$2.83M Buy
13,201
+5,273
+67% +$1.29M 0.13% 145
2022
Q1 		$2.25M Buy
7,928
+1,357
+21% +$418K 0.1% 144
2021
Q4 		$2.48M Buy
6,571
+173
+3% +$67.2K 0.1% 148
2021
Q3 		$2.64M Buy
6,398
+881
+16% +$366K 0.16% 113
2021
Q2 		$2.04M Buy
5,517
+183
+3% +$61.1K 0.16% 125
2021
Q1 		$1.55M Buy
5,334
+4,450
+503% +$1.24M 0.15% 122
2020
Q4 		$221K Buy
+884
New +$211K 0.07% 139

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

NewEdge Wealth's CRL Position: Q2 2026 in Review

NewEdge Wealth opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,091 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #1106 among its holdings. This is a return to the name: NewEdge Wealth previously reported a position in CRL as recently as Q4 2025.

NewEdge Wealth first reported a position in CRL in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.63M in Q1 2024. 567 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • NewEdge Wealth held 1,091 shares of Charles River Laboratories worth $247K as of Q2 2026.
  • Charles River Laboratories was a new NewEdge Wealth position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #1106 holding.
  • NewEdge Wealth first reported a position in Charles River Laboratories in Q4 2020 and has held it in 20 quarters since.
  • NewEdge Wealth's Charles River Laboratories position peaked at $4.63M in Q1 2024.
  • 567 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.